The class of medications known as barbiturates represents one of the most influential milestones in twentieth-century pharmacology. Among these, pentobarbital—widely recognized by its benchmark commercial trade name Nembutal—stands out as a potent short-acting barbiturate derivative. Developed in the early 1930s, pentobarbital was historically deployed for a wide spectrum of clinical applications, ranging from the management […]